CombiGene´s lead project CG01 has received funding from the European Union´s Horizon 2020 research and innovation programme

CombiGene publishes offer document with respect to the offer to the holders of shares and warrants in Panion Animal Health

May 22, 2019

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares or warrants be accepted from or on behalf of holders in Australia, Brazil, Canada, Faroe Islands, Hong Kong, India, Japan, New Zealand, Republic of Korea, Saudi Arabia, Singapore, South Africa, Switzerland, Taiwan, the United Arab Emirates, the United States or any other jurisdiction in which the making of the Offer, the distribution of this press release or the acceptance of any tender of shares or warrants would contravene applicable laws or regulations or require further offer documents, filings or other measures in addition to those required under Swedish law.

For further information, please contact:
Jan Nilsson (CEO)
Phone: +46704663163
E-mail: jan.nilsson@combigene.com

Arne Ferstad (Chairman)
Phone: +447496526142
E-mail: arne.ferstad@ankor-consultants.com

read more >>

Nyheter och rapporter